Cargando…
Importance of the TIMI frame count: implications for future trials
Although the TIMI (Thrombolysis In Myocardial Infarction) flow grade classification scheme is widely used to assess angiographic outcomes, it is limited by poor reproducibility and its categoric nature. The corrected TIMI frame count (CTFC) is a simple, more objective continuous variable index of co...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59594/ https://www.ncbi.nlm.nih.gov/pubmed/11714404 http://dx.doi.org/10.1186/cvm-1-1-031 |
_version_ | 1782120080836919296 |
---|---|
author | Appleby, Mark A Michaels, Andrew D Chen, Michael Michael, C Gibson |
author_facet | Appleby, Mark A Michaels, Andrew D Chen, Michael Michael, C Gibson |
author_sort | Appleby, Mark A |
collection | PubMed |
description | Although the TIMI (Thrombolysis In Myocardial Infarction) flow grade classification scheme is widely used to assess angiographic outcomes, it is limited by poor reproducibility and its categoric nature. The corrected TIMI frame count (CTFC) is a simple, more objective continuous variable index of coronary blood flow that can be broadly and inexpensively applied. This measure of the time for dye to traverse a coronary artery is both accurate (highly correlated with Doppler velocity measurements) and precise (reproducible). The method has been prospectively validated as providing independent risk stratification above and beyond the conventional TIMI flow grades. It has been shown to be a predictor of restenosis, and has been of value in elucidating the underlying pathophysiology of acute myocardial infarction. In view of the above and its ease of use, we anticipate that CTFC will become a widely used method to evaluate coronary blood flow. |
format | Text |
id | pubmed-59594 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2000 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-595942001-11-06 Importance of the TIMI frame count: implications for future trials Appleby, Mark A Michaels, Andrew D Chen, Michael Michael, C Gibson Curr Control Trials Cardiovasc Med Commentary Although the TIMI (Thrombolysis In Myocardial Infarction) flow grade classification scheme is widely used to assess angiographic outcomes, it is limited by poor reproducibility and its categoric nature. The corrected TIMI frame count (CTFC) is a simple, more objective continuous variable index of coronary blood flow that can be broadly and inexpensively applied. This measure of the time for dye to traverse a coronary artery is both accurate (highly correlated with Doppler velocity measurements) and precise (reproducible). The method has been prospectively validated as providing independent risk stratification above and beyond the conventional TIMI flow grades. It has been shown to be a predictor of restenosis, and has been of value in elucidating the underlying pathophysiology of acute myocardial infarction. In view of the above and its ease of use, we anticipate that CTFC will become a widely used method to evaluate coronary blood flow. BioMed Central 2000 2000-08-07 /pmc/articles/PMC59594/ /pubmed/11714404 http://dx.doi.org/10.1186/cvm-1-1-031 Text en Copyright © 2000 Current Controlled Trials Ltd |
spellingShingle | Commentary Appleby, Mark A Michaels, Andrew D Chen, Michael Michael, C Gibson Importance of the TIMI frame count: implications for future trials |
title | Importance of the TIMI frame count: implications for future trials |
title_full | Importance of the TIMI frame count: implications for future trials |
title_fullStr | Importance of the TIMI frame count: implications for future trials |
title_full_unstemmed | Importance of the TIMI frame count: implications for future trials |
title_short | Importance of the TIMI frame count: implications for future trials |
title_sort | importance of the timi frame count: implications for future trials |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59594/ https://www.ncbi.nlm.nih.gov/pubmed/11714404 http://dx.doi.org/10.1186/cvm-1-1-031 |
work_keys_str_mv | AT applebymarka importanceofthetimiframecountimplicationsforfuturetrials AT michaelsandrewd importanceofthetimiframecountimplicationsforfuturetrials AT chenmichael importanceofthetimiframecountimplicationsforfuturetrials AT michaelcgibson importanceofthetimiframecountimplicationsforfuturetrials |